Anavex Life Sciences
AVXL

Anavex Life Sciences (AVXL) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
D. Boral CapitalMaintainedBuy$24.00Mar 31, 2026
D. Boral CapitalMaintainedBuy$24.00Mar 26, 2026
D. Boral CapitalMaintainedBuy$24.00Mar 23, 2026
HC Wainwright & Co.MaintainedBuy$20.00Feb 10, 2026
D. Boral CapitalMaintainedBuy$24.00Feb 9, 2026
D. Boral CapitalMaintainedBuy$24.00Jan 6, 2026
D. Boral CapitalMaintainedBuy$24.00Dec 19, 2025
HC Wainwright & Co.MaintainedBuy$20.00Dec 19, 2025
D. Boral CapitalMaintainedBuy$24.00Dec 15, 2025
HC Wainwright & Co.MaintainedBuy$20.00Nov 28, 2025
D. Boral CapitalMaintainedBuy$24.00Nov 26, 2025
HC Wainwright & Co.MaintainedBuy$20.00 from $42.00Nov 19, 2025
D. Boral CapitalMaintainedBuy$24.00 from $46.00Nov 14, 2025
D. Boral CapitalMaintainedBuy$46.00Oct 29, 2025
Jones TradingDowngradedBuy → HoldOct 24, 2025
HC Wainwright & Co.MaintainedBuy$42.00Oct 7, 2025
D. Boral CapitalMaintainedBuy$46.00Oct 2, 2025
D. Boral CapitalMaintainedBuy$46.00Oct 1, 2025
D. Boral CapitalMaintainedBuy$46.00Sep 10, 2025
HC Wainwright & Co.MaintainedBuy$42.00Sep 10, 2025

Frequently asked questions

  • What is the latest analyst rating on AVXL?

    On Mar 31, 2026, D. Boral Capital maintained Anavex Life Sciences at Buy with a price target of $24.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.